CN110545807B - 用于治疗皮炎和炎性皮肤病的大麻素制剂 - Google Patents

用于治疗皮炎和炎性皮肤病的大麻素制剂 Download PDF

Info

Publication number
CN110545807B
CN110545807B CN201880023264.5A CN201880023264A CN110545807B CN 110545807 B CN110545807 B CN 110545807B CN 201880023264 A CN201880023264 A CN 201880023264A CN 110545807 B CN110545807 B CN 110545807B
Authority
CN
China
Prior art keywords
skin
cbd
cannabinoid
hds
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201880023264.5A
Other languages
English (en)
Chinese (zh)
Other versions
CN110545807A (zh
Inventor
E.库珀
M.卡拉汉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Botanix Pharmaceuticals Ltd
Botanix Pharmaceuticals Inc
Original Assignee
Botanix Pharmaceuticals Ltd
Botanix Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2017900495A external-priority patent/AU2017900495A0/en
Application filed by Botanix Pharmaceuticals Ltd, Botanix Pharmaceuticals Inc filed Critical Botanix Pharmaceuticals Ltd
Priority claimed from PCT/AU2018/050044 external-priority patent/WO2018148785A1/en
Publication of CN110545807A publication Critical patent/CN110545807A/zh
Application granted granted Critical
Publication of CN110545807B publication Critical patent/CN110545807B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
CN201880023264.5A 2017-02-15 2018-01-24 用于治疗皮炎和炎性皮肤病的大麻素制剂 Active CN110545807B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762459363P 2017-02-15 2017-02-15
AU2017900495A AU2017900495A0 (en) 2017-02-15 Formulations of Cannabinoids for the Treatment of Dermatitis and Inflammatory Skin Diseases
AU2017900495 2017-02-15
US62/459,363 2017-02-15
PCT/AU2018/050044 WO2018148785A1 (en) 2017-02-15 2018-01-24 Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases

Publications (2)

Publication Number Publication Date
CN110545807A CN110545807A (zh) 2019-12-06
CN110545807B true CN110545807B (zh) 2022-11-22

Family

ID=67766794

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880023264.5A Active CN110545807B (zh) 2017-02-15 2018-01-24 用于治疗皮炎和炎性皮肤病的大麻素制剂

Country Status (8)

Country Link
US (1) US20210401768A1 (enExample)
EP (1) EP3582768A4 (enExample)
JP (2) JP7012089B2 (enExample)
CN (1) CN110545807B (enExample)
AU (1) AU2018221880B2 (enExample)
BR (1) BR112019017018A2 (enExample)
CA (1) CA3053500A1 (enExample)
IL (1) IL268720B2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020508992A (ja) * 2017-02-15 2020-03-26 ボタニクス ファーマシューティカルズ リミテッド ざ瘡の処置のためのカンナビノイドの製剤
BR112020014911A2 (pt) 2018-01-24 2020-12-08 Botanix Pharmaceuticals Ltd Regime de dosagem de canabinoide para dermatite e condições de pele inflamatórias
CN111000740A (zh) * 2020-01-07 2020-04-14 杭州百芮生物科技有限公司 一种添加大麻提取成分组合物、制备方法及其应用
CN111671885A (zh) * 2020-06-15 2020-09-18 中国人民解放军西部战区总医院 一种用于治疗放射性皮炎的药物
CN111514280A (zh) * 2020-06-15 2020-08-11 中国人民解放军西部战区总医院 一种预防放射性皮炎的药物
CN113479456A (zh) * 2021-04-06 2021-10-08 上海思乐得不锈钢制品有限公司 一种用于储运生物制品的真空容器
US20230039887A1 (en) * 2021-07-20 2023-02-09 Enveric Biosciences, Inc. Compositions for topical treatment of radiation dermatitis
US12059393B2 (en) 2022-02-11 2024-08-13 Akos Biosciences, Inc. Compositions for topical treatment of radiation dermatitis

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003007901A1 (en) * 2001-07-18 2003-01-30 Unilever Plc Hair and/or scalp treatment compositions
WO2008024408A2 (en) * 2006-08-22 2008-02-28 Theraquest Biosciences, Inc. Pharmaceutical formulations of cannabinoids for application to the skin and method of use
WO2012065997A1 (en) * 2010-11-15 2012-05-24 Vib Vzw Respiratory syncytial virus vaccine
WO2015161165A1 (en) * 2014-04-18 2015-10-22 Mary's Medicinals LLC Transdermal cannabinoid patch

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0104268D0 (en) * 2001-02-21 2001-04-11 Unilever Plc Antiperspirant or deodorant compositions
US20080292560A1 (en) * 2007-01-12 2008-11-27 Dov Tamarkin Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
EP2444081B1 (en) * 2010-10-19 2015-04-08 Parenteral, A.S. A composition for the treatment of inflammatory diseases comprising boswellic acids and cannabidiol
US20130184354A1 (en) * 2012-01-13 2013-07-18 Donna K. Jackson Silicone and Hylauronic Acid (HLA) Delivery Systems for Products by Sustainable Processes for Medical Uses Including Wound Management
EP2664327A1 (en) * 2012-05-14 2013-11-20 Almirall S.A. Topical pharmaceutical compositions comprising terbinafide and urea
NZ707855A (en) * 2012-11-06 2018-11-30 Rochal Ind Llc Delivery of biologically-active agents using volatile, hydrophobic solvents
EP3265081A4 (en) * 2015-03-02 2018-11-21 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoids
HK1254812A1 (zh) * 2015-06-23 2019-07-26 APIRx Pharmaceuticals, LLC 包含大麻素的抗微生物组合物

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003007901A1 (en) * 2001-07-18 2003-01-30 Unilever Plc Hair and/or scalp treatment compositions
WO2008024408A2 (en) * 2006-08-22 2008-02-28 Theraquest Biosciences, Inc. Pharmaceutical formulations of cannabinoids for application to the skin and method of use
WO2012065997A1 (en) * 2010-11-15 2012-05-24 Vib Vzw Respiratory syncytial virus vaccine
WO2015161165A1 (en) * 2014-04-18 2015-10-22 Mary's Medicinals LLC Transdermal cannabinoid patch

Also Published As

Publication number Publication date
AU2018221880B2 (en) 2023-08-17
JP2020508994A (ja) 2020-03-26
IL268720A (en) 2019-10-31
EP3582768A4 (en) 2020-11-18
AU2018221880A1 (en) 2019-09-05
BR112019017018A2 (pt) 2020-04-14
IL268720B2 (en) 2024-09-01
JP7012089B2 (ja) 2022-01-27
CN110545807A (zh) 2019-12-06
JP2022050641A (ja) 2022-03-30
US20210401768A1 (en) 2021-12-30
CA3053500A1 (en) 2018-08-23
IL268720B1 (en) 2024-05-01
EP3582768A1 (en) 2019-12-25

Similar Documents

Publication Publication Date Title
CN110545807B (zh) 用于治疗皮炎和炎性皮肤病的大麻素制剂
JP7559173B2 (ja) 皮膚炎および炎症性皮膚状態のためのカンナビノイド投薬レジメン
WO2018148785A1 (en) Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases
CA3053503C (en) Formulations of cannabinoids for the treatment of acne
WO2018148787A1 (en) Formulations of cannabinoids for the treatment of psoriasis
WO2018148786A1 (en) Formulations of cannabinoids for the treatment of acne
Salau et al. Enhancement of transdermal permeation of cannabinoids and their pharmacodynamic evaluation in rats
JP7561252B2 (ja) ざ瘡のためのカンナビノイド投薬レジメン
CN110520123A (zh) 用于治疗银屑病的大麻素制剂

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant